|Bid||3.5900 x 3000|
|Ask||3.6000 x 3100|
|Day's Range||3.5000 - 3.8664|
|52 Week Range||0.8800 - 9.0200|
|Beta (5Y Monthly)||3.03|
|PE Ratio (TTM)||N/A|
|Forward Dividend & Yield||N/A (N/A)|
|1y Target Est||N/A|
Investors need to pay close attention to Arbutus Biopharma (ABUS) stock based on the movements in the options market lately.
It's shaping up to be a tough period for Arbutus Biopharma Corporation (NASDAQ:ABUS), which a week ago released some...
Arbutus (ABUS) delivered earnings and revenue surprises of -35.00% and -15.62%, respectively, for the quarter ended September 2020. Do the numbers hold clues to what lies ahead for the stock?